- Home
- AFMD vs HHS Comparison
AFMD vs HHS Comparison
Compare AFMD & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFMD
- HHS
- Stock Information
- Founded
- AFMD 2000
- HHS 1923
- Country
- AFMD Germany
- HHS United States
- Employees
- AFMD N/A
- HHS N/A
- Industry
- AFMD Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- AFMD Health Care
- HHS Consumer Discretionary
- Exchange
- AFMD Nasdaq
- HHS Nasdaq
- Market Cap
- AFMD 55.6M
- HHS 52.3M
- IPO Year
- AFMD 2014
- HHS N/A
- Fundamental
- Price
- AFMD $3.65
- HHS $6.97
- Analyst Decision
- AFMD Strong Buy
- HHS
- Analyst Count
- AFMD 5
- HHS 0
- Target Price
- AFMD $16.25
- HHS N/A
- AVG Volume (30 Days)
- AFMD 98.0K
- HHS 13.5K
- Earning Date
- AFMD 11-14-2024
- HHS 11-14-2024
- Dividend Yield
- AFMD N/A
- HHS N/A
- EPS Growth
- AFMD N/A
- HHS N/A
- EPS
- AFMD N/A
- HHS N/A
- Revenue
- AFMD $7,959,927.00
- HHS $187,093,000.00
- Revenue This Year
- AFMD N/A
- HHS N/A
- Revenue Next Year
- AFMD $48.98
- HHS $4.05
- P/E Ratio
- AFMD N/A
- HHS N/A
- Revenue Growth
- AFMD N/A
- HHS N/A
- 52 Week Low
- AFMD $2.92
- HHS $6.45
- 52 Week High
- AFMD $8.95
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- AFMD 55.19
- HHS 34.77
- Support Level
- AFMD $3.63
- HHS $6.90
- Resistance Level
- AFMD $3.98
- HHS $7.26
- Average True Range (ATR)
- AFMD 0.24
- HHS 0.23
- MACD
- AFMD 0.04
- HHS -0.03
- Stochastic Oscillator
- AFMD 55.65
- HHS 4.23
About AFMD Affimed N.V.
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.